Article
A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism.
Nature communications - 3 Sept 2015
Krarup Anders, Truan Daphné, Furmanova-Hollenstein Polina, Bogaert Lies, Bouchier Pascale, Bisschop Ilona J M, Widjojoatmodjo Myra N, Zahn Roland, Schuitemaker Hanneke, McLellan Jason S, Langedijk Johannes P M
Abstract excerpt
Respiratory syncytial virus (RSV) causes acute lower respiratory tract infections and is the leading cause of infant hospitalizations. Recently, a promising vaccine antigen based on the RSV fusion protein (RSV F) stabilized in the native prefusion conformation has been described. Here we report alternative strategies to arrest RSV F in the prefusion conformation based on the prevention of hinge movements in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
